Alpharma's vancomycin to be made in Chinese firm's premises

(Reuters) - In a filing on Tuesday with the U.S. Securities and
Exchange Commission, Alpharma said it was seeking the necessary
regulatory approvals to sell the vancomycin produced at the new
site.





Read more at Reuters.com Government Filings News